Hostname: page-component-6bf8c574d5-9nwgx Total loading time: 0 Render date: 2025-02-25T19:02:19.459Z Has data issue: false hasContentIssue false
  • English
  • Français

The effects of integrated treatment with atypical antipsychotics and social cognition training on functional outcome

Published online by Cambridge University Press:  23 March 2020

G. Sachs ,
B. Winklbaur  and
A. Erfurth
G. Sachs*
Affiliation:
Medical University of Vienna, Department of Psychiatry and Psychotherapy, Vienna, Austria
B. Winklbaur
Affiliation:
Medical University of Vienna, Department of Psychiatry and Psychotherapy, Vienna, Austria
A. Erfurth
Affiliation:
Otto-Wagner-Spital, 6th Psychiatric Department, Vienna, Austria
*
* Corresponding author.

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Social cognition is impaired in patients with schizophrenia [1]. This impairment is one of the core features of the illness and has a clear impact on functional outcome.

While conventional antipsychotics might have a worsening effect on social cognition, e.g. on amygdala attenuation in fMRI studies on facial recognition [2], atypical antipsychotics might not show this effect [3].

Social cognitive training [4] – such as the training of affect recognition [5] – is a promising approach in the treatment of schizophrenia.

Holistic strategies including both treatment with atypical antipsychotics and social cognitive training can improve functional outcome in patients with schizophrenia [6].

Disclosure of interest

The author has not supplied his declaration of competing interest.

Type
W39
Information
European Psychiatry , Volume 33 , Issue S1: Abstracts of the 24th European Congress of Psychiatry , March 2016 , pp. S68
Copyright
Copyright © European Psychiatric Association 2016

References

Green, M.F., et al. Nat Rev Neurosci 2015; 16(10):620–631CrossRefGoogle Scholar
Fahim, C., et al. Psychiatry Res 2005; 140(1): 1–15CrossRefGoogle Scholar
Sachs, G., et al. Psychiatry Res 2012; 202(2):168–171CrossRefGoogle Scholar
Kurtz, M.M., et al. Clin Psychol Rev 2015[Epub ahead of print]Google Scholar
Wölwer, W., et al. Schizophr Res 2005; 802–3295–303CrossRefGoogle Scholar
Sachs, G., et al. Schizophr Res 2012; 1382–3262–267CrossRefGoogle Scholar
Submit a response

Comments

No Comments have been published for this article.